USPTO serial 87682587
MEDICAGO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- ROACH, APRIL K
- Law office
- TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with MEDICAGO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
George A. Pelletier, Jr.
GEORGE A. PELLETIER, JR. CANTOR COLBURN LLP20 CHURCH STREET22ND FLOORHARTFORD, CT 06103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for prophylaxis and treatment of infectious diseases, chronic diseases and cancer | ACTIVE | — |
| 035 | Online retail store services, wholesale distributorship services and retail pharmacy stores in the field of pharmaceuticals, pharmaceutical ingredients, vaccines and antibodies | ACTIVE | — |
| 040 | Manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines and antibodies for others | ACTIVE | — |
| 042 | Research and development in the field of vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; medical and scientific research regarding clinical trial studies on new vaccine candidates; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, vaccines, and antibodies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MEDICAGO INC.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named MEDICAGO
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 29, 2019 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 29, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 31, 2019 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 31, 2019 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 31, 2019 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 29, 2019 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jul 6, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 6, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 6, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 5, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 5, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 3, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jun 19, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 24, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 16, 2017 | NWAP | NEW APPLICATION ENTERED | — |